Literature DB >> 30747392

Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.

Christian Johana Baños-Hernández1,2, José Eduardo Navarro-Zarza3, Richard Bucala4, Jorge Hernández-Bello1,5, Isela Parra-Rojas2, María Guadalupe Ramírez-Dueñas6, Samuel García-Arellano1,5, Luis Alexis Hernández-Palma1, Andrea Carolina Machado-Sulbarán6, José Francisco Muñoz-Valle7,8.   

Abstract

INTRODUCTION: Systemic sclerosis (SSc) is a complex autoimmune disease, characterized by microvascular lesions, autoimmunity, and fibrosis. It is suggested that MIF participates in the amplification of the proinflammatory process in SSc; moreover, the promoter polymorphisms - 794 CATT5-8 (rs5844572) and - 173G>C (rs755622) in the MIF gene have been associated with an increase in MIF serum levels in several autoimmune diseases. The aim of this study was to analyze the relationship of the - 794 CATT5-8 and - 173G>C MIF polymorphisms with mRNA expression, MIF serum levels, and the Th1/Th2/Th17 cytokine profile in SSc.
MATERIALS AND METHODS: A case-control study was carried out that included 50 patients with SSc and 100 control subjects (CS). Both polymorphisms were genotyped by PCR and PCR-RFLP. MIF levels were measured by ELISA kit. The cytokine profile and the MIF mRNA expression were quantified by BioPlex MagPix system and real-time PCR, respectively.
RESULTS: An association between the - 794 CATT7 and - 173*C MIF alleles and the 7C haplotype with SSc susceptibility was found (p < 0.05). Also, the 7C haplotype was associated with increased MIF mRNA expression (p = 0.03) in SSc. In addition, an increase of IL-1β and IL-6 serum levels in SSc patients was found as well as a positive correlation between MIF serum levels and Th1 and Th17 cytokine profiles.
CONCLUSION: The MIF 7C haplotype is a susceptibility marker for SSc in the southern Mexican population and is associated with MIF mRNA expression. Moreover, there is a positive correlation between MIF serum levels and Th1 and Th17 inflammatory response in SSc.

Entities:  

Keywords:  Cytokine profiles Th1/Th2/Th17; MIF; MIF mRNA expression; Promoter polymorphisms; Systemic sclerosis

Year:  2019        PMID: 30747392     DOI: 10.1007/s10067-019-04459-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

1.  Recent advances steer the future of systemic sclerosis toward precision medicine.

Authors:  Gemma Lepri; Michael Hughes; Cosimo Bruni; Marco Matucci Cerinic; Silvia Bellando Randone
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

2.  Transforming growth factor beta isoforms and TGF-βR1 and TGF-βR2 expression in systemic sclerosis patients.

Authors:  José Alvaro Lomelí-Nieto; José Francisco Muñoz-Valle; Christian Johana Baños-Hernández; José Eduardo Navarro-Zarza; Juliana Marisol Godínez-Rubí; Samuel García-Arellano; María Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Arisbeth Villanueva-Pérez; Jorge Hernández-Bello
Journal:  Clin Exp Med       Date:  2022-05-29       Impact factor: 3.984

3.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.

Authors:  Theresa H Wirtz; Philipp A Reuken; Christian Jansen; Petra Fischer; Irina Bergmann; Christina Backhaus; Christoph Emontzpohl; Johanna Reißing; Elisa F Brandt; M Teresa Koenen; Kai M Schneider; Robert Schierwagen; Maximilian J Brol; Johannes Chang; Henning W Zimmermann; Nilay Köse-Vogel; Thomas Eggermann; Ingo Kurth; Christian Stoppe; Richard Bucala; Jürgen Bernhagen; Michael Praktiknjo; Andreas Stallmach; Christian Trautwein; Jonel Trebicka; Tony Bruns; Marie-Luise Berres
Journal:  JHEP Rep       Date:  2020-12-17

5.  Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study.

Authors:  Jorge Hernández-Bello; Miroslaba Rodríguez-Puente; Jorge Gutiérrez-Cuevas; Samuel García-Arellano; José Francisco Muñoz-Valle; Mary Fafutis-Morris; Delfina Guadalupe Villanueva-Quintero; Anabell Alvarado-Navarro
Journal:  J Clin Lab Anal       Date:  2021-09-17       Impact factor: 2.352

6.  Association Among MIF, IFIH1, and IL6 Gene Polymorphisms and Non-Segmental Vitiligo in a Chinese Han Population.

Authors:  Danfeng Wang; Shuhui Min; Xiao Lin; Guan Jiang
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-10

7.  Macrophage migration inhibitory factor may play a protective role in osteoarthritis.

Authors:  Ming Liu; Zikun Xie; Guang Sun; Liujun Chen; Dake Qi; Hongwei Zhang; Jieying Xiong; Andrew Furey; Proton Rahman; Guanghua Lei; Guangju Zhai
Journal:  Arthritis Res Ther       Date:  2021-02-20       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.